文献速递医学教育与科研方法临床试验与 GCP

基于注册中心的随机对照试验的多重面向

The multiple facets of registry-based randomised controlled trials.
PubMed 文献 · Trials · 2026-02-11

传统随机对照试验(RCT)长期被视为评价临床干预的金标准,而基于注册中心的试验(RBT)正作为有前景的方法学出现,有望以更高外部有效性、更低复杂性和更低成本产生高质量临床证据。尽管被称为「临床研究的下一项颠覆性技术」,RBT 的采用慢于预期,部分原因在于 RBT 缺乏一致定义,常与基于注册中心的随机对照试验(RRCT)混淆。作者分析七篇 RRCT 综述后发现,RRCT 在临床试验注册平台上的定义与报告存在显著差异,反映缺乏标准化描述词与命名法,导致其实施与影响难以准确估计;作者据此提出基于注册中心如何支持 RCT 的 RRCT 分类法,并欢迎 RRCT 报告 CONSORT 扩展版、倡导标准化注册方法。

要点

  • RBT 有望以更高外部有效性、更低复杂性和更低成本产生高质量临床证据。
  • RBT 采用慢于预期,部分原因在于缺乏一致定义,常与 RRCT 混淆。
  • 七篇 RRCT 综述显示注册平台上的定义与报告存在显著差异。

核心结论

  • RRCT 是解决关键研究问题的有价值方法,但需清晰一致的定义和标准化注册术语的共识才能实现其全部潜力。
  • 作者提出基于注册中心如何支持 RCT 的 RRCT 分类法,并欢迎 RRCT 报告 CONSORT 扩展版、倡导标准化注册方法。
  • 作者提出基于注册中心捕获结局数量及其用于识别或招募参与者的两级 RRCT 分类,并鼓励围绕 RRCT 分类法持续讨论以指导未来研究。

研究设计与样本

  • 作者分析了七篇 RRCT 综述,考察 RRCT 在临床试验注册平台上的定义与报告情况。

主要发现

  • 七篇 RRCT 综述显示 RRCT 的定义与报告存在显著差异,反映注册时缺乏标准化描述词与命名法。
  • 这种模糊性使 RRCT 的实施与影响难以准确估计,表现为各综述报告的注册为 RRCT 的试验数量差异很大。

关键数值与推荐

  • 作者提出基于注册中心如何支持 RCT 的 RRCT 分类法。
  • 作者提出基于注册中心捕获结局数量及其用于识别或招募参与者的两级 RRCT 分类。

临床怎么用

  • 作者欢迎 RRCT 报告 CONSORT 扩展版,并倡导临床试验注册平台采用标准化注册方法。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Traditional randomised controlled trials (RCTs) have long been considered the gold standard for evaluating clinical interventions. However, registry-based trials (RBTs) are emerging as a promising methodology, offering the potential for generating high-quality clinical evidence with greater external validity, reduced complexity, and lower costs. Despite being hailed as the "next disruptive technology in clinical research", the adoption of RBTs has been slower than anticipated. This lag could be attributed, in part, to the lack of consistent definitions for RBTs, which are often conflated with registry-based RCTs (RRCTs). Our analysis of seven RRCT reviews revealed significant variability in how RRCTs are defined and reported across clinical trial registries, reflecting the absence of standardised descriptors and nomenclature when registering these trials on clinical trial registries. This ambiguity complicates accurate estimation of their implementation and impact, reflected in reviews reporting widely varying numbers of trials registered as RRCTs. While RRCTs represent a valuable approach for addressing critical research questions, for their full potential to be realised, clear and consistent definitions, along with consensus on standardised registration terms, are essential. Given this, we would propose a taxonomy for RRCTs based on how the registry is used to support a RCT. We also welcome the CONSORT extension for the reporting of RRCTs and advocate for a standardised approach on how they are registered on clinical trial registries. Achieving this would not only enhance the recognition of RRCTs but also their impact on clinical practice. We propose a two-tier RRCT classification based on the number of outcomes captured in the registry and its use for identification or recruitment of participants, and encourage ongoing discussion around RRCT taxonomy to help guide future research.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Karanatsios B, Prang KH, Gibbs P, et al. The multiple facets of registry-based randomised controlled trials. Trials. 2026. PMID: 41673760. doi:10.1186/s13063-026-09444-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。